Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (40)
NITAG documentation (1632)
Reports (61)
SAGE documentation (226)
Scientific publications (120)
Systematic reviews (SYSVAC) (3034)
Regions
Africa (294)
Americas (787)
Eastern Mediterranean (58)
Europe (736)
Global (1)
South-East Asia (82)
Western Pacific (212)
Diseases
Chikungunya (12)
Cholera (35)
COVID-19 (1568)
Cytomegalovirus (1)
Dengue (42)
Diphtheria (89)
Ebola (18)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (168)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (75)
HIV / AIDS (10)
Human papillomavirus (HPV) (526)
Influenza (623)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (31)
Measles (143)
Meningococcal disease (153)
Moraxella catarrhalis (1)
Mpox (56)
Mumps (49)
Pertussis (120)
Pneumococcal disease (299)
Poliomyelitis (93)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (66)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (13)
Tuberculosis (83)
Typhoid (31)
Varicella (76)
Yellow fever (44)
Zika (1)
Show more
5113 results found
2022
Evidence to Decision: second IPV dose
2022
∙
WHO
GRADE table: IPV-only vaccination schedule
2022
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, October 2022: conclusions and recommendations
2022
∙
WHO
Polio vaccines: WHO position paper – June 2022
2022
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, April 2022: conclusions and recommendations
2022
∙
SAGE
Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19
2022
Standard terminology and principles for vaccine delivery costs
2022
Guidelines on Interagency Coordinating Committees
2022
∙
CoPI
Recommendation on the introduction of the Malaria vaccine
2022
Recommendations from the Higher Council for Infectious Diseases for vaccination against pneumococcus for populations at risk adults (18 years and over) or aged 65 and over
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register